ArticleScientific reports2020
Defining eligible patients for allele-selective chemotherapies targeting NAT2 in colorectal cancer.
Veronica Rendo et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
4 papers cite it
this papercites it